BLOG

Sunday, September 6, 2020

Analysts positive on Jubilant Life despite 52% dip in Q1 profit; here's why

Barring unforeseen circumstances, the management expects strong performance in their Pharma, Life Science Ingredients, and Drug Discovery and Development Solutions business

from Home Page https://ift.tt/35b44GO
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...